Search

everythinglearnresearchcommunity

for

Search:↓

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Certain gene variations are linked to higher male hormone levels in Chinese women with PCOS and insulin resistance.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Women with moderate body hair have higher levels of certain hormones and may benefit from treatment that increases sex hormone-binding protein.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.